The French Anti-Doping Agency is authorised to create an automated personal data processing system to facilitate the exchange of information relating to Therapeutic Use Exemptions between this Agency, National Anti-Doping Agencies, the World Anti-Doping Agency, organisations responsible for major events within the meaning of 2° of Article L. 230-3 and international sports federations.
This processing brings together data concerning the substance which is the subject of an authorisation or the method to which it relates, its dosage and its route of administration.